Merck Closes Plants, Lays Off 16,000
As part of its plan to save $3.5 billion by 2012, Merck announced on Thursday the “phasing out” of eight manufacturing sites, as well as eight research sites.
» MORE

Berwick Appointed Head of CMS
With a long, hard fight looming, President Obama decided to go around Congress to install Don Berwick, founder of the Institute for Healthcare Improvement, as the top administrator of the Centers for Medicaid and Medicare Services.
» MORE

HIV Market Banking on Fixed-Dose Treatments
With the looming patent expiration of many high-profile HIV cocktail treatments, pharma is going to see a deep decline in sales. Will single-dose HIV treatments be the answer?
» MORE

Response to the Fiscal Crisis: The Valuing Conversation
As Europe sets the pace in slashing drug prices to meet austerity goals industry is seeking fresh ways to control the fallout. Will more dialogue be enough?
» MORE

Crackdown on the C-Suite
Lewis Morris, top lawyer in HHS's office of inspector general, explains his new move to target pharma execs for serious and ongoing healthcare fraud.
» MORE

Certified Letter
The Medical Representative Certification Commission is embarking on a new mission to rebuild rep’s trust in the eyes of physicians. Pharm Rep examines MRCC’s progress and asks, will it work?
» MORE

Physicians Stay Put
A new study indicates that doctors are no longer switching offices—largely due to current economic woes. What does this mean for sales reps? Pharm Exec interviews SK&A to find out more about its survey.
» MORE

The Fine Art of Selling
Great salespeople are passionate ambassadors of excellence argues a regional district sales manager
» MORE

When the Bubble Burst
Between 1995 and 2006 the number of sales reps ballooned to more than 100,000 amid blockbusters and new marketing tactics. Then the model broke. Can pharma learn from its mistakes?
» MORE